Roivant Sciences Ltd.
ROIV | NASDAQ
$36.31
-$0.60 (-1.63%)
Nov 2, 2026, 11:21 AM ET · Market open
Fiscal Year Period Ending | FY 2025 Mar 31, 2026 | FY 2024 Mar 31, 2025 | FY 2023 Mar 31, 2024 | FY 2022 Mar 31, 2023 | FY 2021 Mar 31, 2022 | FY 2020 Mar 31, 2021 |
|---|---|---|---|---|---|---|
Cash & Equivalents | 1.42B | 2.72B | 6.54B | 1.68B | 2.06B | 2.13B |
Short-Term Investments | 2.87B | 2.17B | 5.37M | 5.01M | n/a | n/a |
Long-Term Investments | 415.88M | 302.94M | 247.75M | 304.32M | 325.83M | 398.47M |
Other Long-Term Assets | 33.02M | 32.86M | 39.11M | 49.48M | 25.82M | 27.2M |
Receivables | 789.84M | n/a | 82.81M | 37.64M | 6.73M | 13.83M |
Inventory | n/a | n/a | 35.25M | 2.76M | n/a | n/a |
Other Current Assets | 81.86M | 113.17M | 17.6M | 20.44M | 26.02M | 874K |
Total Current Assets | 5.17B | 5B | 6.73B | 1.8B | 2.15B | 2.19B |
Property-Plant & Equipment | 92.4M | 101.08M | 65.95M | 92.34M | 86.95M | 77.03M |
Goodwill & Intangibles | n/a | n/a | 137.84M | 144.88M | n/a | n/a |
Total Long-Term Assets | 560.66M | 436.88M | 490.65M | 591.02M | 438.61M | 502.7M |
Total Assets | 5.73B | 5.44B | 7.22B | 2.39B | 2.59B | 2.69B |
Account Payables | 18M | 23.69M | 53.23M | 37.83M | 34.58M | 20.55M |
Deferred Revenue | n/a | 1.17M | 4.17M | 12.44M | 10.15M | 5.92M |
Short-Term Debt | 11.15M | 9.84M | 12M | 40.72M | n/a | 12.31M |
Other Current Liabilities | 119.08M | 53.93M | 85.94M | 74.85M | 44.26M | 141.42M |
Total Current Liabilities | 281.24M | 149.41M | 266.76M | 272.45M | 184.37M | 218.96M |
Long-Term Debt | n/a | n/a | 430.59M | 375.52M | 210.03M | 170.28M |
Other Long-Term Liabilities | 38.74M | 10M | 29.34M | 80.58M | 53.1M | 76.06M |
Total Long-Term Liabilities | 154.39M | 100.33M | 507.2M | 509.57M | 339.33M | 308.73M |
Total Liabilities | 435.63M | 249.74M | 773.95M | 782.02M | 523.7M | 527.69M |
Total Debt | 107.44M | 100.17M | 499.75M | 481.4M | 283.89M | 244.98M |
Book Value | 5.29B | 5.19B | 6.45B | 1.61B | 2.06B | 2.16B |
Book Value Per Share | 7.63 | 7.15 | 7.76 | 2.26 | 3.08 | 3.16 |
Common Stock | n/a | n/a | n/a | n/a | n/a | n/a |
Retained Earnings | -501.81M | 116.06M | 576.17M | -3.77B | -2.76B | -1.92B |
Comprehensive Income | 4.36M | 9.44M | -4.08M | -2.62M | -946K | 1.45M |
Shareholders Equity | 4.53B | 4.69B | 5.97B | 1.16B | 1.66B | 1.9B |
Total Investments | 3.29B | 2.47B | 253.12M | 309.33M | 325.83M | 398.47M |
Add to Watchlist
Select watchlists to add or remove ROIV